A Worldwide Antihistamine-Refractory Chronic Urticaria Patient Evaluation in Latin America and Canada (AWARE-LACan)
Clinical trial NCT02626221 · COMPLETED
Trial details
- NCT number
- NCT02626221
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-12-24
- Primary completion
- 2018-03-21
- Enrollment
- 497
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.